<VariationArchive RecordType="classified" VariationID="3343" VariationName="NM_000348.4(SRD5A2):c.753del (p.Phe252fs)" VariationType="Deletion" Accession="VCV000003343" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2015-10-11" MostRecentSubmission="2015-10-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18382" VariationID="3343">
      <GeneList>
        <Gene Symbol="SRD5A2" FullName="steroid 5 alpha-reductase 2" GeneID="6716" HGNC_ID="HGNC:11285" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="31522480" stop="31663009" display_start="31522480" display_stop="31663009" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="31749655" stop="31806039" display_start="31749655" display_stop="31806039" Strand="-" />
          </Location>
          <OMIM>607306</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000348.4(SRD5A2):c.753del (p.Phe252fs)</Name>
      <CanonicalSPDI>NC_000002.12:31526207:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="31526208" stop="31526208" display_start="31526208" display_stop="31526208" variantLength="1" positionVCF="31526207" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="31751278" stop="31751278" display_start="31751278" display_stop="31751278" variantLength="1" positionVCF="31751277" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>P251del</Name>
      </OtherNameList>
      <ProteinChange>F252fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.31751278del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.31751278del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.31526208del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.31526208del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008365.1" sequenceAccession="NG_008365" sequenceVersion="1" change="g.59764del">
            <Expression>NG_008365.1:g.59764del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000348.4" sequenceAccession="NM_000348" sequenceVersion="4" change="c.753del" MANESelect="true">
            <Expression>NM_000348.4:c.753del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000339.2" sequenceAccession="NP_000339" sequenceVersion="2" change="p.Phe252fs">
            <Expression>NP_000339.2:p.Phe252fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340076" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607306.0008" DB="OMIM" />
        <XRef Type="rs" ID="587776567" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000348.4(SRD5A2):c.753del (p.Phe252fs) AND 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency" Accession="RCV000003507" Version="3">
        <ClassifiedConditionList TraitSetID="853">
          <ClassifiedCondition DB="MedGen" ID="C0268297">3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1998-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-10-11" MostRecentSubmission="2015-10-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9467575</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="853" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5821" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Male pseudohermaphroditism due to 5-alpha-reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial incomplete male pseudohermaphroditism, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency</ElementValue>
                <XRef ID="57514000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudovaginal perineoscrotal hypospadias</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency</ElementValue>
                <XRef ID="MONDO:0009923" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPSH</ElementValue>
                <XRef Type="MIM" ID="264600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5680" />
                <XRef ID="5680" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508993" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="753" DB="Orphanet" />
              <XRef ID="C0268297" DB="MedGen" />
              <XRef ID="MONDO:0009923" DB="MONDO" />
              <XRef Type="MIM" ID="264600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23665" SubmissionDate="2016-06-20" DateLastUpdated="2015-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607306.0008_PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS" title="SRD5A2, 1-BP DEL, PRO251DEL _PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS" />
        <ClinVarAccession Accession="SCV000023665" DateUpdated="2015-10-11" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Can et al. (1998) studied the molecular genetics of a large isolated inbred Turkish kindred with male pseudohermaphroditism (PPSH; 264600) due to either 5-alpha-reductase-2 (SRD5A2) or 17-beta hydroxysteroid dehydrogenase-3 (HSD17B3; 605573) gene defects. Using SSCP analysis and DNA sequencing, a new mutation in exon 5 of the SRD5A2 gene was detected in some male pseudohermaphrodites from this kindred. This single base (adenine) deletion caused a frameshift at amino acid position 251, resulting in the addition of 23 amino acids at the C terminus of this 254-amino acid isozyme. Expression of the mutant isozyme in CV1 cells showed a complete loss of enzymatic activity in the conversion of [14C]testosterone to dihydrotestosterone, without a change in the mRNA level compared to that of the wildtype isozyme. Analysis of the HSD17B3 gene in other male pseudohermaphrodites from this kindred revealed a G-to-A transition at the boundary between intron 8 and exon 9, disrupting the splice acceptor site of exon 9 (605573.0006). In addition to finding male pseudohermaphrodites with either a homozygous SRD5A2 or HSD17B3 gene defect in this kindred, other affected males were found to be genetically more complex, e.g., homozygous for the SRD5A2 defect and heterozygous for the HSD17B3 defect, or homozygous for the HSD17B3 defect and heterozygous for the SRD5A2 defect. Also, phenotypically normal carriers were identified with either one or both gene defects. Homozygous male pseudohermaphrodites with SRD5A2 or HSD17B3 gene defects were phenotypically distinguishable by the presence of mild gynecomastia in the latter. Hormone data were consistent with the particular homozygous gene defect. The authors concluded that 2 gene defects, one in SRD5A2 and the other in HSD17B3, can each cause male pseudohermaphroditism in a large isolated Turkish kindred, and that the 2 defects segregate independently and can be inherited from 2 different progenitors. They stated that the analysis of a new mutation in exon 5 of the SRD5A2 gene supported the functional importance of the C terminus of the SRD5A2 isozyme.</Attribute>
              <Citation>
                <ID Source="PubMed">9467575</ID>
              </Citation>
              <XRef DB="OMIM" ID="264600" Type="MIM" />
              <XRef DB="OMIM" ID="605573" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SRD5A2" />
          </GeneList>
          <Name>SRD5A2, 1-BP DEL, PRO251DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, PRO251DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607306.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23665" TraitType="Disease" MappingType="Name" MappingValue="PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS" MappingRef="Preferred">
        <MedGen CUI="C0268297" Name="3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

